Orshe

Johnson & Johnson announced another recall today, this time pulling about 360,000 products sold in the U.S. for use draining surgical wounds, Dow Jones Newswires reports.

J&J’s Ethicon unit, which makes the Blake Silicone Drains, J-VAC reservoirs and other withdrawn products, says it hasn’t received any reports of side effects. The company said it decided to recall the devices after customers complained the sterile packaging could be compromised.

Also: a quick guide to states’ planned Medicaid cuts; asking for clarification on health-care overhaul ruling; how to talk about cancer.

Go here to read the rest:  A.M. Vitals: J&J-FDA Tussle Highlights Medical Device Approval Debate

A new report shows that a slower regulatory process in the U.S. doesn’t result in fewer device recalls.

Read the original: AdvaMed-Sponsored Report Says Safety Not Improved By Longer Approval Process

Also: HHS announces fraud figures; Sanofi and Genzyme, still talking; an FDA panel weighs electroshock therapy.

The rest is here:  A.M. Vitals: Senate May Vote on Health-Care Law Repeal

The PwC report says that med tech innovators are increasingly going outside the U.S. “to seek clinical data, new-product registration and first revenue.”

Excerpt from:  Will Medical Technology Innovation Shift to Emerging Markets?

Radiation-therapy dose errors are the top tech health hazard, according to ECRI Institute.

See original here:  The Top Ten Health Technology Threats to Patient Safety

Boston Scientific has said the market could someday be as big as $5 billion.

See more here:  Medtronic’s Ardian Purchase is a Bet on New Anti-Hypertension Tech

Also: radiation concerns over dental CT scanners; gap in oversight on medical device manufacturing; STD rates.

Read more here:  A.M. Vitals: Johnson & Johnson Recalls Kids’ Benadryl, Motrin

An industry-funded study finds devices were available in the U.S. “an average of two full years later” than in other countries.

More:  FDA Medical Device Review Process: Too Fast or Too Slow?